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INTRODUCTION
It is well known that the presence of neck nodal metastasis is
the most important prognostic factor of survival and the region-
al recurrence is the most frequent cause of treatment failure
after surgical removal for patients with squamous cell carcino-
ma (SCC) of the oral tongue (1). Treatment failures with even
fatal outcome can occur in patients who initially have presented
very small primary tumor with clinically negative neck (2, 3). 
Several studies demonstrated 13-33% and 27-53% of occult
nodal metastasis in stage I and II, respectively (2, 4). However,
there has been a lot of controversy over the management of occult
neck disease of early stage oral tongue cancer for more than 3
decades: elective neck dissection (END) versus observation. Some
studies have shown no survival benefit, reduction of recurrence
or other advantages when the clinically negative neck is treated
with END (1, 5, 6), while others have described reduced region-
al recurrence or prolonged survival (3, 7-9). Therefore, to choose
properly between close observation or END as the management
for clinically negative neck in patients with early stage SCC of the
oral tongue (T1-2N0M0), it is essential to find the patients who
have a great risk for occult nodal metastasis and regional recur-
Objectives. This study analyzed various clinical and histopathologic factors for patients with early stage squamous cell
carcinoma (SCC) of the oral tongue to define a high risk group for regional recurrence and finally to find out the
indication of elective neck dissection (END).
Methods. Retrospective chart review was performed for 63 patients with T1-T2N0 SCC of the oral tongue who under-
went partial glossectomy with/without END. Clinical and histopathologic factors assessed were age, gender, clini-
cal T stage, tumor cell differentiation, depth of invasion, pathologic nodal status, and intrinsic muscle involvement,
perineural invasion, lymphovascular emboli and resection margin involvement. 
Results. Five year overall survival rate was 97.1% in stage I and 76.2% in stage II, and 5-yr disease free survival rate
was 76.7% in stage I and 43.5% in stage II. Rates of occult nodal metastasis in stage I and II were 15.4% and 42.9%,
respectively. Overall regional recurrence rate was 15.9%, which consisted of 10.2% in stage I and 35.7% in stage
II. The success rate of salvage treatment was 100% in stage I and 40% in stage II. Higher T stage, higher histologic
grade, depth of invasion ≥3 mm, presence of intrinsic muscle involvement were significantly related to regional
recurrence (P=0.035, P=0.011, P=0.016, P=0.009, respectively). In stage I, the non-END group (n=36) showed
13.9% of regional recurrence rate, while END group (n=13) did not have any regional recurrence (P=0.198). Five
year disease free survival rate of END group was significantly higher than non-END group (100% and 68.7%,
respectively, P=0.045). 
Conclusion. We recommend to perform END in early stage SCC of the oral tongue if the primary tumor has T2 stage,
and T1 stage with higher histologic grade, depth of invasion more than 3 mm, or presence of intrinsic muscle
involvement.
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Original Articlerence. Several studies have evaluated the value of certain clini-
cohistologic factors in predicting the probability of occult nodal
metastasis, such as age, gender, T stage, N stage, depth of inva-
sion, histologic grade, perineural and lymphvascular invasion,
resection margin and etc (10, 11).
The aim of this study was to analyze various clinical and his-
topathologic factors for patients with T1-T2N0 SCC of the oral
tongue treated primarily by surgery, in an attempt to better
define a subgroup at high risk for regional recurrence and final-
ly to find out the indication of END.
MATERIALS AND METHODS
Subjects
We reviewed the medical records of 105 patients of SCC of the
oral tongue who had been treated initially at the Department of
Otorhinolaryngology-Head and Neck Surgery in Seoul National
University Hospital between 1987 and 2006. The subjects of
this study were limited to patients with stage I/II (T1-2N0M0)
SCC of the oral tongue. N0 was considered when there is no
palpable lymph node by physical examination and size of the
lymph node is less than 1 cm by computed tomography (CT) or
magnetic resonance imaging without any area suggestive of
central necrosis or metastasis. M0 was considered when there is
no evidence of distant metastasis by liver sonography, bone scan
and chest x-ray, or by PET. Staging was based on the AJCC’s
Manual for Staging of Cancer (2002, Sixth edition). 
Thirty-five patients with stage III and IV were excluded. And 7
of 70 patients with early stage tumor who ether developed sec-
ondary malignancy, underwent neoadjuvant chemotherapy or be
treated by radiotherapy alone were excluded. Ultimately, 63 pati-
ents were eligible for this retrospective study. All patients under-
went partial glossectomy intraorally with/without unilateral END.
The male to female ratio was 1.25:1 (35 males and 28 fe-
males). The mean age of the patients was 56 yr (range, 26-88
yr). The preoperative clinical stage was cT1N0M0 in 49 and
cT2N0M0 in 14 patients. The follow-up period ranged from 12
to 191 months, with a median of 59 months.
Clinical and histopathologic factors assessed included age (<40
vs. ≥40 yr), gender, clinical T stage (T1 vs. T2 stage), tumor
cell differentiation (well vs. moderate vs. poor), depth of inva-
sion (<3 vs. ≥3 mm), pathologic nodal status, and presence or
absence of intrinsic muscle involvement, perineural invasion,
lymphovascular emboli and resection margin involvement.
Histopathologic findings were reviewed by a single pathologist
with hematoxylin- and eosin-stained histologic sections of tumor.
Statistical methods
All statistical analyses were performed using SPSS software for
Windows (version 13.0, SPSS, Chicago, IL, USA). Variables were
independently tested for their relation to presence of regional
recurrence using the 
2 test or Fisher’s exact test. Multiple logis-
tic regression was used to identify the multivariate correlates of
regional recurrence. 
We used the Kaplan-Meier method and the log-rank test to
compare the overall survival and disease-free survival between
the patients with stage I and II, and between those with END
and without it. P-value less than 0.05 was considered indicative
of statistical significance.
RESULTS
Regional recurrence and occult nodal metastasis
Of 63 patients, 10 showed regional recurrence during follow-up
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Fig. 1. (A) Five year overall survival rate in stage I and II of squamous cell carcinoma of the oral tongue. (B) Five year disease free survival rate
in stage I and II of squamous cell carcinoma of the oral tongue.
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Bperiod, and overall regional recurrence rate was 15.9%. The
average time from initial treatment to regional recurrence was
8 months (range 2-43 months). Twenty patients including 13 in
stage I and 7 in stage II underwent END, and 5 of them were
revealed to have pathologic positive nodes. Rates of occult nodal
metastasis in stage I and II were 15.4% (2/13) and 42.9% (3/7),
respectively.
Survival for early SCC of the oral tongue in Seoul
National University Hospital
Five year overall survival rate was 97.1% in stage I and 76.2% in
stage II. Patients in stage I showed higher 5-yr overall survival
rate than in stage II with statistical significance (P=0.006) (Fig.
1A). Five year disease free survival rate of stage I was higher
than that of stage II with statistical significance, 76.7% vs. 43.5%,
respectively (P=0.012) (Fig. 1B). 
In 46 patients without any type of recurrence, 5-yr survival rate
was 100%. However, 5-yr survival rate was 83.3% in 7 patients
with local recurrence, and 67.5% in 10 with regional recurrence.
Patients with regional recurrence showed lower survival rate
than patients with local recurrence with statistical significance
(P=0.001) (Fig. 2).
Among 10 patients with regional recurrence after initial sur-
gical treatment, all 5 of stage I were successfully salvaged by
modified radical neck dissection with/without postoperative
radiotherapy. However, only 2 of 5 patients of stage II were
salvaged by modified radical neck dissection with/without post-
operative radiotherapy. One patient was alive with disease, and
other 2 were dead of disease on the last follow-up in spite of
neck dissection, postoperative radiotherapy or adjuvant chemo-
therapy. Therefore success rate of salvage treatment was 100%
in stage I and 40% in stage II.
Factors related to regional recurrence
In univariate analysis using the 
2 test or Fisher’s exact test, clin-
ical factors including gender and age groups divided at 40 yr were
not significantly related to regional recurrence. Histopathological
factors including resection margin ≤5 mm, perineural invasion
and lymphovascular emboli of the primary tumor were not sig-
nificantly related to regional recurrence. In cases with patholog-
ically positive node, there was a tendency of higher incidence of
regional recurrence than in cases with negative one, 0% vs. 40%,
respectively, but it did not reach statistical significance (P=0.053).
The incidence of regional recurrence was 10.2% and 35.7% in
clinical T1 and T2 stage, respectively. Higher T stage was signif-
icantly related to regional recurrence (P=0.035). Patient with
higher histologic grade, depth of invasion ≥3 mm and intrinsic
muscle involvement from histopathologic findings showed a sig-
nificantly higher incidence of regional recurrence (P=0.011, P=
0.016, P=0.009, respectively) (Table 1). 
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Fig. 2. Survival according to type of recurrence in squamous cell
carcinoma of the oral tongue.
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Table 1. Univariate analysis for factors related to regional recurrence
Sex
Male 35 5 (14.3) 0.740
Female 28 5  (17.9)
Age (yr)
<40 10 0  (0) 0.341
≥40 53 10  (18.9)
Clinical T stage
T1 49 5  (10.2) 0.035
T2 14 5  (35.7)
Histologic grade
Well differentiated 44  4 (9.1) 0.011
Moderate differentiated 18  5 (27.8)
Poorly differentiated 1  1 (100)
Depth of invasion
<3 mm 17  0 (0) 0.016
≥3 mm 38  10 (26.3)
Intrinsic muscle involvement 
No 22 0  (0) 0.009
Yes 41 10  (24.4)
Perineural invasion
No 41 7  (17.1) 0.670
Yes 7 1  (14.3)
Lymphovascular emboli
No 37 6  (16.2) 0.550
Yes 10 2  (20.0)
Resection Margin
>5 mm 26  5 (19.2) 1.0
≤5 mm 25  5 (19.6)
Pathologic nodal stage
pN0 15 0  (0) 0.053
pN+ 5 2  (40)In multivariate analysis using logistic regression, T stage, his-
tologic grade, depth of invasion, and intrinsic muscle involve-
ment which were the significant related factors to regional recur-
rence on univariate analysis were introduced, but there was no
statistical significance. This result was considered as because
these factors had a close relation to each others, that is, multi-
collinearity, especially between T stage, depth of invasion and
intrinsic muscle involvement. When performed only about T
stage and histologic grade, T stage showed a strong relationship
to regional recurrence significantly (P=0.011), which means that
T stage can be a single most powerful prognostic factor of region-
al recurrence in early stage SCC of the oral tongue (Table 2, 3).
Neck dissection in clinical T1N0
All 49 patients in stage I underwent partial glossectomy with or
without END, and divided into two groups: END group (n=13)
and non-END group (n=36). The non-END group showed 13.9%
of regional recurrence rate, while END group did not have any
regional recurrence (Fischer’s Exact Test, OR=0.861, P=0.198),
however this difference did not reach statistical significance.
Five year disease free survival rates of non-END and END groups
showed a significant difference (68.7% and 100%, respective-
ly, P=0.045) (Fig. 3). However, 5-yr overall survival rates had
no difference (96% and 100%, respectively, P=0.527), because,
all 5 patients with regional recurrence were successfully salvaged
by modified radical neck dissection with/without postoperative
radiotherapy. The related factors for regional recurrence in stage
I were also evaluated as previously studied. Histologic grade and
intrinsic muscle involvement were significantly related (P=0.007,
P=0.042, respectively) and depth of invasion ≥3 mm had a
tendency to increase the incidence of regional recurrence (P=
0.071) (Table 4).
DISCUSSION
In our institute, 5-yr overall survival rate was 97.1% in stage I
and 76.2% in stage II for early stage SCC of the oral tongue.
Overall rate of regional recurrence was 15.9%. Regional recur-
rence was the most common type of recurrence and related to
lowest survival rate. Overall salvage rate after regional recur-
rence was 70% in our series, whereas it was about 30-40% in
many other studies (3, 6, 12, 13). Our better outcome may result
from thorough physical examination with every month follow-
up till 1 yr after surgery and regular imaging follow up with CT. 
Friedlander et al. presented that patients younger than 40 yr
with SCC of the oral tongue had a higher rate of locoregional
recurrence rate than did older patients (14), whereas Davison
et al. concluded that increasing age predicted worse disease-
specific survival (15). Fukano et al. demonstrated that depth of
invasion exceeding 5 mm was statistically significantly correlat-
ed with cervical metastases (16) and O’Brient et al. presented
that prognosis changed significantly at a cutoff of 4 mm of depth
of invasion (17). Sparano et al. reported that greater tumor thick-
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Factors P-value
Table 2. Multivariate analysis for factors related to regional recur-
rence (I)
T2 > T1 0.098
Higher histologic grade 0.255
Depth of invasion ≥3 mm 0.998
Involvement of intrinsic muscle 0.998
Factors P-value
Table 3. Multivariate analysis for factors related to regional recurrence
(II)
T2 > T1 0.011
Higher histologic grade 0.107
Variable
No. of
patients 
Univariate analysis
Regional 
recurrence (%)
P-value
Table 4. Univariate analysis for factors related to regional recur-
rence in T1N0
Histologic grade
Well differentiated 33 2 (6.1) 0.007
Moderate differentiated 15 2 (13.3)
Poorly differentiated 1  1 (100)
Depth of invasion
<3 mm 16 0 (0) 0.071
≥3 mm 25 5 (20)
Intrinsic muscle involvement 
No 22 0  (0) 0.042
Yes 27 5 (18.5)
Fig. 3. Five year disease free survival rates of non-END and END
groups. END: elective neck dissection.
C
u
m
u
l
a
t
i
v
e
 
s
u
r
v
i
v
a
l
1.0
0.8
0.6
0.4
0.2
0.0
0 50 100 150 200
Months
END group
Non-END group170 Clinical and Experimental Otorhinolaryngology  Vol. 1, No. 3: 166-170, September 2008
ness, greater depth of muscle invasion, T2 stage, poorly differ-
entiated tumors, infiltrating-type front, presence of perineural
invasion and presence of angiolymphatic invasion correlated
positively to occult neck metastasis (10). Factors related to neck
recurrence in early stage SCC of the oral tongue were found to
be T stage, depth of invasion, intrinsic muscle involvement and
histologic grade, while age, gender, perineural invasion and
lymphovascular emboli, resection margin and pathologic nodal
stage were not significantly related in our series.
The management of the N0 neck in early stage SCC of the
oral tongue has been the subject of heated debate over the years.
Keski-Santti et al. presented that for stage I and II of oral tongue
SCC, there were significantly fewer regional recurrences in pati-
ents with END, but statistical differences in overall or disease
specific survival between END and non-END group were not
found. They concluded that the risk for occult cervical metasta-
sis was high in patients with early tongue tumors and only care-
fully selected patients could be left without prophylactic neck
treatment (3). It is generally recommended that for SCC of the
upper aerodigestive tract, the clinically N0 neck should be treat-
ed when the incidence of occult metastasis is greater than 20%
(18). In our series, rate of occult nodal metastasis was 42.9% in
stage II, and T2 stage was the most important factor for regional
recurrence through univariate and multivariate analysis. There-
fore patients with clinical stage T2N0 were justified in undergo-
ing END to reduce regional recurrence and improve survival.
Then, when END should be performed in T1N0 SCC of the oral
tongue? Fernando et al. (13) found in T1N0 SCC patients of the
oral tongue and mouth floor that 24% of non-END group devel-
oped regional recurrences in comparison with 4% of END group,
and that END group had a 23% higher disease-free survival rate
than non-END group. In T1N0 SCC patients of oral tongue in
our series, the rate of occult nodal metastasis was 15.4%, and
the END group showed a lower incidence of regional recurrence
and higher disease free survival rate than END group. However,
5-yr overall survival rates had no difference between two groups,
because all 5 patients with regional recurrence were successful-
ly salvaged by modified radical neck dissection with/without
postoperative radiotherapy. Despite of high success rate of sal-
vage treatment, recurrence of cancer is a fear to patients and
regular follow-up is difficult for some patients. Therefore patients
with higher possibility of regional recurrence, which means those
with factors related to regional recurrence as described above,
had better undergo END. 
In conclusion, we obtained successful survival rate in early
stage SCC of the oral tongue treated by, mainly, surgery. And
we should consider performing the END in following cases: T2
stage, and T1 stage with higher histologic grade, depth of inva-
sion more than 3 mm, or presence of intrinsic muscle involvement.
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